Cochlear share price lifts on 21% dividend boost

The hearing implants company reports record FY23 revenue and a juicy reward for investors.

| More on:
a small girl smiles and holds her ears as if listening to a noise in an outdoor setting.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cochlear Limited (ASX: COH) share price is rising after the hearing implants company posted its FY23 full-year results.

The Cochlear share price opened at $244.73, up 4.93% on yesterday's close. It's currently trading at $251.30, 7.76% higher.

Cochlear reported record annual revenue of $1,956 million and strong growth across all business units.

And there's a juicy reward for investors with the final dividend boosted by 21% to $1.75 per share.

Let's review the details.

Cochlear share price leaps on record revenue

Here are the highlights of the full-year report:

  • Sales revenue $1,956 million, up 19% on the prior corresponding period (pcp) of FY22
  • Statutory net profit $301 million, up 4% pcp
  • Underlying net profit $305 million, up 10% and at the top end of the guidance range
  • 70% franked final dividend of $1.75 per share, up 21% pcp and payable 11 October.

What else happened in FY23?

Cochlear said the launch of the Nucleus 8 Sound Processor late in the second quarter generated strong demand for implants and sound processor upgrades.

The company said an "improving trend in adult referral rates is providing us with early indications that awareness and access initiatives are having some success".

In FY23, Cochlear purchased $30 million in shares as part of a progressive $75 million on-market share buyback to reduce its cash balance to about $200 million over the coming years.

ASX investors were supportive of the share buyback plan announced in February alongside the company's half-year results. The Cochlear share price rose by 7.75% on the day the results were released.

Created with Highcharts 11.4.3Cochlear PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

What did Cochlear management say?

Cochlear management says:

As we look to the future, we remain confident of the opportunity to grow our markets.

There remains a significant, unmet and addressable clinical need for cochlear and acoustic implants that is expected to continue to underpin the long-term sustainable growth of the business.

In a separate presentation lodged today, Cochlear says:

We helped over 44,000 people hear with one – or two – of our cochlear or acoustic implants [in FY23], providing an estimated net societal benefit of more than $7 billion over the lifetime of the recipients from improved health outcomes, educational cost savings and productivity gains (up 15%).

What's next for Cochlear?

In terms of FY24 guidance, Cochlear says it expects to deliver underlying net profit of $355 million to $375 million, which would be a 16% to 23% increase on FY23.

Guidance is based on currency assumptions of a 67 cent AUD/USD (67.5 cent average in FY23) and a 61 cent AUD/EUR (64.4 cent average in FY23).

The guidance does not factor in the proposed acquisition of Oticon Medical's cochlear implants business. This is due for completion at the end of December 2023.

Cochlear intends to invest about 12% of its sales revenue in research and development in FY24.

Cochlear share price snapshot

The Cochlear share price is up 10% over the past 12 months and up 20% in the year to date.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A woman is excited as she reads the latest rumour on her phone.
Earnings Results

Guess which ASX retail stock is rocketing 31% on results day?

Great day for investors.

Read more »

Business people discussing project on digital tablet.
Earnings Results

Mirvac Group FY25 earnings: return to growth in sight

Mirvac Group posted FY25 profits and distributions in line with guidance, with rising residential sales and renewed growth targeted for…

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Earnings Results

Cochlear FY25 earnings: revenue and profit climb, dividend up 5%

Cochlear lifted profit and revenue in FY25.

Read more »

A woman's hair is blown back and her face is in shock at this big news.
Earnings Results

Temple & Webster shares soar on 500% profit explosion

The Temple & Webster share price ripped 11% higher to a new record of $29.06 on Thursday.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Earnings Results

Pro Medicus reports 39% profit jump in FY25 and record contracts

Pro Medicus shares have jumped 7% after reporting its FY25 result.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Bank Shares

Westpac shares are surging higher on 14% quarterly profit boost

Investors are piling into Westpac shares on Thursday. But why?

Read more »

Five workers working on a task in a warehouse.
Earnings Results

Orora FY25 earnings: Profit up, transformation complete

Orora reported double-digit profit growth.

Read more »

a man in a business suit sits at his laptop computer at his desk and smiles broadly in an office setting, giving an air of optimism and confidence.
Earnings Results

Ventia Services Group share price: H1 earnings lift profit, guidance, and buyback

Ventia Services Group delivered higher profit and work in hand, lifted guidance, and boosted its buyback program for FY25.

Read more »